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Low-grade MALT-type lymphomas are malignancies of mucosal marginal-zone B cells and
preceded by reactive inflammatory lymphoid tissue. Experimental observations suggest that
antigen and CD40 Ligand act during cognate T/B cell interaction and are crucial for germinal
center B-cell maturation generating marginal-zone B cells. To investigate the mechanisms
underlying the development of extranodal MALT-type lymphomas, the immunoglobulin
receptor was sequenced and analyzed for antigen specificity using heterohybridoma technology.
Furthermore, CD40 ligand expression was evaluated by immunohistochemistry and by
semiquantitative RT-PCR, and ligand binding to the CD40 of tumor B cells was studied using
the CD40 system. Hypermutations were found in low-grade lymphomas throughout CDR1-
CDR3 suggestive of positive selection through their antigen receptor. Different VH families
were used and more than 69% of tumor immunoglobulins bound different mucosal antigens.
CD40L expression was found in the tumor marginal zone in substantial amounts. The in vitro
proliferation response of all low-grade MALT-type lymphomas was dependent on anti-CD40-
mediated signals and cytokines. Our data provide evidence that autoantigen as well as the
CD40L expressed by activated nonneoplastic T cells may drive the evolution of low-grade
MALT-type lymphomas either directly or by paracrine mechanisms and that antigen may
contribute to lymphoma pathogenesis.
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INTRODUCTION
More than one-third of non-Hodgkin lymphomas
(NHL) arise at sites other than lymph nodes, the so-
called extranodal lymphomas (Isaacson and Spencer,
1987). They are almost all ofB cell origin and emerge
preferentially in the stomach, an organ primarily
devoid of preexisting mucosa-associated lymphoid
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TABLE VH Gene Analysis of Low-Grade MALT-Type Lymphoma with a Pattern of Somatic Mutations
Case ClosestVH member No. of nucleotide difference (total in) R:S
VHgene family Germ-line genomic Identity FR1 CDR1 FR2 CDR2 FR3 (CDRs FRs) CDRs FRs
VHI hv1263 94% 2 4 9 6 11 6.0 0.8
2 VHI hv35 95% 3 0 5 5 6 8 6.0 6.0
3 VHIII hv3005 95% 4 2 4 3 7 7 4.0 0.4
4 VHIV VH4-21 94% 3 4 2 2 5 6 10 4.0 1.25
tissue (MALT). Highly organized lymphoid tissue of
MALT-type, however, is formed as a consequence of
chronic inflammation. Since morphological and func-
tional features of this lymphoma are similar to
primary MALT, it has been designated secondary
MALT (Greiner and Mtiller-Hermelink, 1996). The
conditions leading to secondary MALT are con-
sidered as important preconditions of lymphomagene-
sis at extranodal sites (Isaacson, 1994).
It has been suggested that marginal-zone B cells are
the normaI counterpart to MALT-type lymphoma
tumor cells. The former are noncirculating memory B
cells and generated during T cell-dependent antigen
responses (Dunn Walters et al. 1995). Experimental
observations suggest ’that antigen and CD40/CD40
ligand (T-BAM, TRAP) act during cognate T/B cell
interaction and are crucial checkpoints for germinal-
center B cell maturation generating marginal-zone B
cells (Arpin et al., 1995; Han et al., 1995). The
maturation of B cells into efficient producers of high-
affinity and high-specificity antibodies is regulated by
various T cell subsets through cell-surface molecules
and soluble cytokines (Banchereau et al., 1994). In
particular, IL-2, IL-4, IL-6, and IL-10 have been
demonstrated to be crucial for B cell maturation
(Fluckiger et al., 1993; Briere et al., 1994; Burdin et
al., 1995).
Therefore, T cells may determine not only the type
of B cell immune response but may also provide key
molecules in B cell lymphoma initiation and progres-
sion as well. Both, the histopathological and clinical
features of MALT-type lymphomas suggest the
possibility that the lymphomagenesis is, at least in
part, antigen-dependent.
RESULTS
Tumor Antigen Receptor Is Hypermutated and
Recognizes Autoantigen
Analysis of the VH regions of MALT lymphomas
showed usage of different VH families (Table I) (Qin
et al., 1995). Additionally, compared with the germ-
line, the VH gene of each tumor contained at least 14
substitutions. They were distributed in a pattern
characteristic for an antigen-driven affinity matura-
tion, that is, the somatic mutations were highly
concentrated in the CDRs and FRs with a clustering
of replacement [R] mutations in the CDRs, but only
few in the FRs. Three of the four genes detected here,
hv1263, hv3005, and VH4-21, are frequently used in
a variety of autoantibodies, such as cold agglutinins,
rheumatoid factors and anti-DNA antibodies (Dersi-
monian et al., 1987; Sanz et al., 1989; Olee et al.,
1991).
Analysis of the Tumor Immunoglobulin
Specificity
The antibody specificity of monoclonal antibodies
derived from 13 low- and high-grade MALT-type
lymphomas of the stomach, thyroid, salivary gland,
and the lung were analyzed by using heterohybridoma
technology. Tumor immunoglobulin from 9 of 13
patients (69%) had autoantibody activity (Table II).
The target antigens of the lymphoma immunoglobulin
have been found to be autoantigens mainly expressed
in mucosal tissues, for example, of thyroid, parotid,
lung, or stomach tissue. The human Abs bound to
different self-determinants and fullfilled the definitionPATHOGENESIS OF MALT-TYPE LYMPHOMA 189
TABLE II Tumor Immunoglobulin Specificity on Human Cryostat Sections














ANA, salivary gland, thyroid epithelium
Small blood vessels
Salivary gland, foveolar epithelium in the stomach




ANA, salivary gland, thyroid epithelium, glandular epithelium in the stomach
Thyreoglobulin
of an autoantibody since they are self-reactive, but not
self-specific. These monoclonal antibodies (mAbs)
were highly specific for the identified antigen and
bound none of the other tested antigens that are
commonly recognized by polyreactive natural auto-
antibodies (e.g., rheumatoid factor, myosin, and
actin).
The Tumor Antigen Receptor Is Functionally
Active
By using an anti-idiotypic antibody highly specific for
a gastric IgA-expressing low-grade MALT lymphoma
immunoglobulin receptor (idiotype), induction of the
proliferation response after cross-linking was induced
by additional stimulation with a mitogen. A specific
growth promotion effect of the anti-idiotype antibody
in combination with SAC was noted in the lymphoma
cells but not in controls. The effect of the anti-
idiotype antibody induced proliferation was more
pronounced than the effect of cytokine or mitogen
stimulation alone (Figure 1A). This may indicate a
dependency on additional signals. Furthermore, stim-
ulation with the anti-idiotype antibody induced a
differentiation of tumor cells, as demonstrated by an
enhanced secretion of tumor IgA (Fig. lb), but not of


























Fig. Stimulation of purified tumor B cells of IgA-expressing MALT-type lymphoma and follicular nodal lymphoma as neoplastic and
tonsilar as non-neoplastic B cells as control. (A) 5 104 purified B cells were cultured in triplicate over 5 days. [3H]TdR uptake was
measured after a 16-hr pulse. Note the enhanced proliferation of MALT tumor B cells but not of controls using the anti-ld antibody. (B)
Differentiation ofMALT tumor B cells using the anti-ld antibody as demonstrated by IgA-secretion. This effect of the anti-idiotype antibody
was found only in the tumor, but not in tonsilar or nodal tumor B cells. Within the latter, only SAC was able to induce differentiation as
demonstrated by IgM-secretion (C).190 A. GREINER et al.
CD40 Receptor Is Expressed by Tumor B Cells
and CD40 Ligand Is Present in Tumor Tissue
All investigated and freshly isolated MALT lym-
phoma B cells expressed high levels of CD40 on their
cell surfaces (Fig. 2). Nontumor T cells expressing
CD40L were found within the tumor marginal zone
by in situ immunohistochemistry. By using a semi-
quantitative RT-PCR, CD40L was found to be
increased in tumor tissues of low-grade MALT-type
lymphomas in contrast to controls (reactive, nonneo-
plastic tissues) (Fig. 3).
Functional Consequences of Antigen Receptor
and CD40 Engagement in MALT Lymphoma
To determine whether the tumor cell response in low-
grade lymphoma is due to a stimulatory effect of




Fig. 3 Semiquantitative RT-PCR using GADPH as a standard
showing CD40L message in cases of low-grade MALT-type B cell
lymphomas.
infiltrating T cells the B cells were cultured in the so-
called "CD40-system," which allowed to study the
properties of tumor B cells and nontumor T cells
independently (Fig. 4). Herein the proliferative B cell







Fig. 2 CD40 histogram of a multicolor FACS analysis of MALT
lymphoma B cell suspension freshly isolated after surgery and
gated for viable lymphocytes, CD19+, CD40+, and 7-AAD, as
described (Schmid et al., 1992).
Eltonsil
[] MALT #4
Fig. 4 Anti-CD40-activated normal and lymphoma B cells show different growth
kinetics in culture period. 5 X104 purified B cells were cultured in triplicate over
5 days. [3H]T dR upta are representative of three independent experiments.PATHOGENESIS OF MALT-TYPE LYMPHOMA 191





#1 #2 #3 #4
Medium <0.05 <0.05 <0.05 <0.05 <0.05
IL-2 <0.05 <0.05 <0.05 <0.05 <0.05
IL-4 <0.05 <0.05 <0.05 <0.05 <0.05
IL- 10 0.18 7.34 6.68 10.23 4.22
IL-10 + IL-2 0.42 7.22 6.99 9.58 4.45
IL- 10 + IL-4 0.22 7.28 7.29 10.63 4.87
a5 X 10 B cells were cultured during 5 days in the CD40 system. Antibody production was measured by ELISA.
investigated was strongly dependent on anti-CD40-
mediated signals, complemented by cytokines pro-
duced by T helper cells of the Th2 type (IL-4 and/or
IL-10). Thl cytokines (IL-2 and/or INFy) had little
effect. No difference to B cells isolated from normal
tonsils was detected. Furthermore, low-grade MALT-
type lymphoma B cells were induced to secrete large
amounts of tumor immunoglobulin in response to
IL-10 (Table III). This antibody secretion by tumor B
cells was significantly more pronounced than in
normal B cells and could not be enhanced by adding
IL-2 or IL-4 alone or in combination.
In contrast to CD40 ligand signaling, B-cell-
receptor (BCR) triggering induced spontaneous cell
death in normal tonsil but not in MALT lymphoma B
cells in vitro (Fig. 5) reminiscent of apoptosis of
germinal-center B cells in vivo.
DISCUSSION
To get an insight into the pathogenesis of MALT-type
lymphomas, it was the aim of the present study to
investigate the eventual correlation between two
observations made independently with B cell lympho-
mas in general and MALT lymphomas in particular:
The first observation concerns the high frequency of
"anti-self" or autoimmune reactivity of immunoglo-
bulins secreted both by nodal lymphomas like CLL
and follicular B cell lymphomas as well as by
lymphomas ofMALT (Hussell et al., 1993; Greiner et
al., 1994a). The second observation made only in
MALT lymphoma is that they are preceded by
reactive inflammatory tissue. So far, however, it has
not been defined whether antigen and paracrine
factors contribute to lymphoma development.





medium CD40L a-lg CD40L+a-lg
Fig. 5 Highly purified tonsil and tumor B cells of a thyroid low-grade MALT-type lymphoma were cultured over 5 days either with medium
alone or recombinant human CD40 ligand (CD40L) or anti-BCR (a-lg) as an antigen trigger, as described (Galibert et al., 1996). Viable cells
were visualized using Trypan blue staining. Note a marked decrease of tonsil but not tumor B cells using a-Ig.192 A. GREINER et al.
In particular, recent work about CD5 chronic
lymphatic leukemia (B-CLL) (Schroeder, Jr. and
Dighiero, 1994) or CD5- follicular lymphoma
(Kobayashi et al., 1993) has provided strong evidence
that a high percentage of B cells that express
immunoglobulin with reactivity against self-determi-
nants are frequently committed to malignancy. In
contrast to MALT lymphoma, a restricted repertoire
of immunodominant epitopes on the target antigen(s)
of the lymphoma immunoglobulin (idiotype) is dis-
played in CLL, follicular and mantle cell lymphoma,
as exemplified by a high frequency of shared
idiotypes within these tumors (Dighiero, 1992; Rud-
ders et al. 1992; Ohno et al., 1995). Consequently, the
immunoglobulins of MALT-type lymphomas exhibit
a highly, restricted specificity for a variety of
distinctive (auto)antigens confined to MALT (e.g.,
mucosal plasma cells, thyroid, salivary gland, lung
and stomach epithelia) that does not share idiotop
within extranodal or nodal lymphomas (Greiner et al.
1994a).
This may be explained at the molecular level by the
finding that MALT-lymphoma immunoglobulin gene
sequences were found frequently in a variety of
autoantibodies. They displayed somatic hypermuta-
tions, indicating affinity maturation during a specific
antigen response that may alter the binding to the
initiating antigen thus leading to a variety of different
and highly specific autoantibodies (Schroder et al.,
1996). The putative antigen binding to MALT-tumor
immunoglobulin is still unknown and.could be an
exogenous antigen, a regulatory ce-idiotype antibody
or an autoantigen. In this regard, experimental data
favor the latter possibility.
Autoreactivity in MALT-type lymphoma may have
consequences in at least two ways. First, it empha-
sizes the recent hypothesis that proliferation in some
MALT-type lymphomas may be antigen-driven, and
autoimmunity may play a role in their pathogenesis
(Mtiller-Hermelink et al., 1995). This hypothesis is
strengthened by the observation that the antigen
receptor of MALT lymphomas is functionally active
and can induce tumor-cell survival (Fig. 5). Second,
according to the concept of the recently proposed
REAL classification (Harris et al., 1994), the
immunological and molecular data have helped to
define MALT-type lymphoma with respect to their
extraordinary pathophysiological features.
Whether antigen-driven affinity maturation is asso-
ciated with secondary events that cause tumor trans-
formation in MALT Lymphoma is uncertain. As in
most nodal lymphomas, the etiology and pathogenesis
of lymphomas derived from MALT are not yet
elucidated. In particular, unifying chromosomal abe-
rration (Roblick et al., 1993; Wotherspoon et al.,
1995), rearrangements of oncogenes (Marin et al.
1995), or Epstein-Barr virus infections (Ott et al.,
1993; Greiner et al., in press), thought to be first steps
in the development of nodal lymphomas, have not
been detected in lymphomas of MALT type. It is
possible that antigen is necessary for survival of the
initiating malignant tumor clone in combination with
paracrine factors supported by reactive tumor infiltrat-
ing T cells that express CD40 ligand. In this regard, it
was important that large amounts of CD40L were
detected in MALT lymphoma tissues in vivo and that
the tumor B cells responded to the CD40 ligand signal
in vitro. The activation of the malignant B cells
parallels the activation of normal mature B cells
resulting in B-cell proliferation and differentiation
depended on the added cytokine. In contrast, CD40
cross-linking was found to inhibit cell proliferation in
other lymphoma types, like Burkitt lymphoma, dif-
fuse large-cell lymphoma, or lymphoblastoid cell
lines (Funakoshi et al., 1994).
Therefore, our data provide certain evidence that
autoantigen as well as the CD40L expressed by
activated non-neoplastic T cells may trigger evolution
of low-grade MALT-type lymphomas either directly
or by paracrine mechanisms and that antigen may
contribute to lymphoma pathogenesis.
MATERIAL AND METHODS
Tissues, Cell Culture, and B-Cell Purification
Non-neoplastic tonsillar tissues and malignant lym-
phomas were obtained from biopsies after surgical
removal for the preparation of cell suspensions, snap-
freezing in liquid nitrogen, and routine fixation forPATHOGENESIS OF MALT-TYPE LYMPHOMA 193
histological examination. In all cases, the diagnosis
was confirmed by morphological and immunopheno-
typical analysis of fresh-frozen and paraffin-embed-
ded sections. Mononuclear single-cell suspensions
were isolated by density-gradient centrifugation and
negatively depleted with magnetic beads coupled
either with anti-CD2,-CD14 mAbs (Dynal, Ger-
many). Thereafter, lymphoma cells were further
purified by negative depletion of non-neoplastic
bystander B cells using beads coated with antibodies
to heavy and light chains not expressed by the
lymphoma, including IgD. The purity of lymphocyte
cell suspensions obtained after magnetic immuno-
beads depletion was between 97.5 and 99.7% B cells,
as calculated by FACScan analysis.
Purified normal and tumor B cells were cultured in
RPMI1640 supplemented with 1% gentamycin, 10%
FCS, and 50/zg/ml transferrin (Sigma, St. Louis). For
activation through CD40 antigen, B cells were
cultured in the presence of 0.1/g/ml anti-CD40 mAb
89 (J. Banchereau, Dardilly, France) presented by a
mouse Ltk- cell line stably expressing CDw32
according to the experimental procedure described
previously (Banchereau and Rousset, 1991). Recom-
binant cytokines were added at the onset of culture.
DNA synthesis was determined as measured by [3H]
TdR incorporation as described (Greiner et al.,
1994b).
Tumor Immunoglobulin and c-Idiotypic
Antibodies
MALT-type lymphoma immunoglobulins were pro-
duced by fusing lymphoma cells with the hetero-
myeloma NSO and selected by corresponding to the
lymphoma immunoglobulin as described recently
(Greiner et al., 1994b). Monoclonal anti-idiotypic
antibodies were produced by immunizing mice with
purified tumor immunoglobulin. Mouse immuno-
globulin-secreting hybridomas were cloned by limit-
ing dilution and selected by exhibiting a restricted
specificity in immunohistochemistry, Western-blot,
and competitive ELISA for the tumor antigen receptor
and not for controls (Greiner et al., 1991).
Flow Cytometry
Flow cytometric analysis was performed on a FACS-
can (Becton-Dickinson) with an Argon ion laser tuned
at 488 nm using LYSIS II for data acquisition and
analysis using triple immunostaining with directly
conjugated antibodies: CD19 (HD 37, sigma); kappa
(Dako, Hamburg); lambda (Dako); CD3 (UCHT-1,
Sigma); CD14 (Leu-M3; Becton-Dickinson); CD40
(mAb89; Banchereau and Rousset, 1991).
ELISA
Supernatants were assayed in ELISA as described
recently (Greiner et al., 1994a) using microtiter plates
(Falcon, FRG) coated with goat anti-human heavy-
chain (Dako). After blocking with 0.5% BSA, undi-
luted samples were added for 2 h at 37C. Finally, the
plates were developed with rabbit anti-human heavy-
chain HRP conjugate (Dako) and orthophenyl-dia-
mine with hydrogen peroxide in citrate phosphate
buffer and read at 490 nm in an automatic ELISA
reader (Merlin, FRG). The sensitivity of the assay was
< 10 ng/ml.
RNA Extraction
All tumor tissue blocks were snap-frozen in liquid
nitrogen and stored at -70C until extraction of
RNA. Total RNA was prepared (TRIzol reagent; Life
Technology, Paisley, UK) from 20 sections of about
10 #m from the frozen tumor tissue blocks. Integrity
of RNA was controlled by electrophoresis through a
2% formaldehyde-agarose gel and the yield of RNA
was quantitated by measuring the optical density. To
check for carryover of material during the isolation
step, extraction buffer without tissue was used as a
negative control.
cDNA Synthesis
First-strand synthesis was performed with 1 /zg of
total cellular RNA. RNA, 2/g of dT-15 primer, and
DEPC-treated water to give a final volume of 8 #1
were incubated for 10 min at 65C. After chilling on
ice, a master mix consisting of dNTPs and dithiother-
eitol (final concentrations of mmol/1 each and 10194 A. GREINER et al.
mmol/1, respectively), 25 U of recombinant RNAse
inhibitor (Promega, Heidelberg), RT-buffer and
200 U of moloney-murine leukemia virus reverse
transcriptase (GIBCO BRL) were added to a final
reaction volume of 25/zl. After 70 min of incubation
at 37C, the samples were heated to 98C for 4 min.
The efficiency of cDNA synthesis was estimated by
PCR with glyceraldehyde-3-phosphate dehydro-
genase (GAPDH)-specific primers.
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